Augmented Reality for Subdural Hematoma
Trial Summary
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Augmented Reality for Subdural Drain Placement?
Research shows that augmented reality (AR) can improve the accuracy of placing drains in the brain, which is similar to the procedure for subdural hematoma. AR has been used successfully in other brain procedures, like placing ventricular drains, by helping surgeons see exactly where to place the drain, leading to better outcomes.12345
Is augmented reality for subdural hematoma treatment safe?
How does augmented reality for subdural drain placement differ from other treatments for subdural hematoma?
Augmented reality (AR) for subdural drain placement is unique because it uses advanced technology to guide the surgeon with real-time visual overlays, improving accuracy and reducing errors compared to traditional freehand methods. This approach can also shorten the learning curve for surgeons, making it easier to perform the procedure correctly.234511
What is the purpose of this trial?
This study involves using a augmented reality (AR) system to assist in the placement of a subdural evacuating portal system (SEPS). In the first part of the study, all participants will have skin marking of an AR-guided and non-AR-guided site to determine feasibility and method accuracy. In the second part, subjects will be randomized to AR-guided and non-AR-guided SEPS placement to determine efficacy.
Research Team
Vivek Buch, MD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for individuals with a subdural hematoma, which is a type of brain bleed that requires drainage. Participants must be candidates for a procedure using the Subdural Evacuating Portal System (SEPS). They cannot join if they are unable to undergo CT scans or if they are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pilot Usability
Five patients will be enrolled to test whether the AR device functions appropriately, but no clinical decisions or changes to care will be determined by the AR device at this point.
Treatment
Participants are randomized to AR-guided and non-AR-guided SEPS placement to determine efficacy.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including symptom score assessment and radiographic measures.
Treatment Details
Interventions
- Augmented Reality for Subdural Drain Placement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor